* BLUEBELL CAPITAL SENDS LETTER TO CHAIRMAN OF GSK
* BLUEBELL CAPITAL SAYS BELIEVES GSK SHOULD ADDRESS IN THE SHORT TERM, THE LEADERSHIP FOR “NEW GSK”
* BLUEBELL CAPITAL: ASK GSK BOARD TO ACCELERATE FURTHER APPOINTMENTS TO GSK BOARD WITH OBJECTIVE TO INCREASE BIOPHARMACEUTICALS, SCIENTIFIC EXPERIENCE
* BLUEBELL CAPITAL: ASKS GSK TO LAUNCH IMMEDIATELY AFTERWARDS THOROUGH, ROBUST PROCESS TO IDENTIFY BEST(INTERNAL OR EXTERNAL) CANDIDATE TO LEAD NEW GSK
* BLUEBELL CAPITAL: ASKS GSK TO TAKE A PROACTIVE APPROACH TO CONSIDER AVAILABLE ALTERNATIVE TRANSACTIONS TO DEMERGER OF CONSUMER HEALTHCARE
* BLUEBELL CAPITAL SAYS VIEWS GSK VACCINE FRANCHISE AS GENERALLY UNDERVALUED BY MARKET - LETTER
* BLUEBELL WRITES TO GSK IN RELATION TO INVESTMENT AND/OR ECONOMIC INTEREST IN GSK COMMON EQUITY SHARES BY BLUEBELL ACTIVE EQUITY MASTER FUND ICAV
* BLUEBELL CAPITAL SAYS BELIEVES GSK'S EMMA WALMSLEY WOULD HAVE BEEN A VERY CREDIBLE CANDIDATE FOR THE POSITION OF CEO AT CONSUMER HEALTHCARE
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.